An exploration into the diagnostic capabilities of microRNAs for myocardial infarction using machine learning
- PMID: 39658789
- PMCID: PMC11629498
- DOI: 10.1186/s13062-024-00543-5
An exploration into the diagnostic capabilities of microRNAs for myocardial infarction using machine learning
Abstract
Background: MicroRNAs (miRNAs) have shown potential as diagnostic biomarkers for myocardial infarction (MI) due to their early dysregulation and stability in circulation after MI. Moreover, they play a crucial role in regulating adaptive and maladaptive responses in cardiovascular diseases, making them attractive targets for potential biomarkers. However, their potential as novel biomarkers for diagnosing cardiovascular diseases requires systematic evaluation.
Methods: This study aimed to identify a miRNA biomarker panel for early-stage MI detection using bioinformatics and machine learning (ML) methods. miRNA expression data were obtained for early-stage MI patients and healthy controls from the Gene Expression Omnibus. Separate datasets were allocated for training and independent testing. Differential expression analysis was performed to identify dysregulated miRNAs in the training set. The least absolute shrinkage and selection operator (LASSO) was applied for feature selection to prioritize relevant miRNAs associated with MI. The selected miRNAs were used to develop ML models including support vector machine, Gradient Boosted, XGBoost, and a hard voting ensemble (HVE).
Results: Differential expression analysis discovered 99 dysregulated miRNAs in the training set. LASSO feature selection prioritized 21 miRNAs. Ten miRNAs were identified in both the LASSO subset and independent test set. The HVE model trained with the selected miRNAs achieved an accuracy of 0.86 and AUC of 0.83 on the independent test set.
Conclusions: An integrated framework for robust miRNA selection from omics data shows promise for developing accurate diagnostic models for early-stage MI detection. The HVE model demonstrated good performance despite differences between training and test datasets.
Keywords: Bioinformatics; Diagnosis; Machine learning; MicroRNA; Myocardial infarction.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was approved by the research ethics committee of Tabriz University of Medical Sciences (approval ID: IR.TBZMED.VCR.REC.1399.388, date of approval: 2021/1/11). Consent for publication: All authors gave consent for the publication of the article Competing interests: The authors declare that they have no Conflict of interest.
Figures





References
-
- Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease: Analysis of data from the World Health Organization and coronary artery disease risk factors From NCD Risk Factor Collaboration. Circ Cardiovasc Qual Outcomes. 2019;12(6): e005375. 10.1161/CIRCOUTCOMES.118.005375. - PMC - PubMed
-
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618–51. 10.1161/CIR.0000000000000617. - PubMed
-
- Schulte C, Barwari T, Joshi A, Zeller T, Mayr M. Noncoding RNAs versus Protein Biomarkers in Cardiovascular Disease. Trends Mol Med. 2020;26(6):583–96. 10.1016/j.molmed.2020.02.001. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical